Towards New Efficacy Paradigms in Newly Diagnosed Multiple Myeloma (NDMM) Patients: A Phase III GEM/PETHEMA Trial Project to Comparing the Current International Standard VRD [VRD (X 6) + Plus Transplant and Consolidation (VRDx2)] Vs. an Extended VRD (x18 Cycles) Including also Transplant, and Early Redirecting of 1st Line to Alternative Therapy if Unfavorable Response Kinetic is Observed

Entidad: Asociación Española contra el Cáncer Ref: GCB IPs: María Victoria Mateos, Juan José Lahuerta Duración: 2021-2027

Pin It en Pinterest